Safety and Efficacy of 8 Weeks Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 4 in Children Aged 4-10 Years
Behairy, Behairy E., El-Araby, Hanaa A., El-Guindi, Mohamed A., Basiouny, Hosam-Eldin M., Fouad, Ola A., Ayoub, Bassam A., Marei, Ayman M., Sira, Mostafa M.
Published in The Journal of pediatrics (01.04.2020)
Published in The Journal of pediatrics (01.04.2020)
Get full text
Journal Article
Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9–12 years) and adolescents
El-Araby, Hanaa A., Behairy, Behairy E., El-Guindi, Mohamed A., Adawy, Nermin M., Allam, Alif A., Sira, Ahmad M., Khedr, Mohamed A., Elhenawy, Ibrahim A., Sobhy, Gihan A., Basiouny, Hosam El Din M., Salem, Menan E., Abdel-Aziz, Samira A., Fouad, Ola A., Ayoub, Bassam A.
Published in Hepatology international (01.11.2019)
Published in Hepatology international (01.11.2019)
Get full text
Journal Article
Hepatic progenitor cells in children with chronic hepatitis C: correlation with histopathology, viremia, and treatment response
El-Araby, Hanaa A, Ehsan, Nermine A, Konsowa, Hatem A, Abd-Elaati, Basma M, Sira, Ahmad M
Published in European journal of gastroenterology & hepatology (01.05.2015)
Published in European journal of gastroenterology & hepatology (01.05.2015)
Get more information
Journal Article